Literature DB >> 14551887

Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy.

Evan Wood1, Julio S G Montaner, Mark W Tyndall, Martin T Schechter, Michael V O'Shaughnessy, Robert S Hogg.   

Abstract

We evaluated all human immunodeficiency virus (HIV)-related deaths over the period 1 January 1995-31 December 2001 in a Canadian province in which all HIV care and antiretroviral therapy are provided free of charge. Persons who had received antiretroviral drugs before death were compared with those who had died without ever receiving HIV treatment, by fitting a logistic model. Overall, 1239 deaths were attributed to HIV infection during the study period. Of these, 406 (32.8%) occurred among persons who had never received any HIV treatment. In adjusted analyses, aboriginal ethnicity, female sex, and lower median income were negatively associated with receiving HIV treatment before death. Furthermore, among the 833 individuals who received treatment before death, only 379 (45.5%) received antiretroviral medication >or=75% of the time during their first year receiving therapy. The data demonstrate the need for novel interventions to expand HIV care to specific populations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14551887     DOI: 10.1086/378703

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  38 in total

Review 1.  Deadly public policy: what the future could hold for the HIV epidemic among injection drug users in Vancouver.

Authors:  Michael V O'Shaughnessy; Robert S Hogg; Steffanie A Strathdee; Julio S G Montaner
Journal:  Curr HIV/AIDS Rep       Date:  2012-12       Impact factor: 5.071

2.  Psychosocial factors in adherence to antiretroviral therapy among HIV-positive people who use drugs.

Authors:  William K Lee; M J S Milloy; John Walsh; Paul Nguyen; Evan Wood; Thomas Kerr
Journal:  Health Psychol       Date:  2015-12-21       Impact factor: 4.267

3.  Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users.

Authors:  Sasha Uhlmann; M-J Milloy; Thomas Kerr; Ruth Zhang; Silvia Guillemi; David Marsh; Robert S Hogg; Julio S G Montaner; Evan Wood
Journal:  Addiction       Date:  2010-03-10       Impact factor: 6.526

Review 4.  The population effectiveness of highly active antiretroviral therapy: are good drugs good enough?

Authors:  Thomas P Giordano; Maria E Suarez-Almazor; Richard M Grimes
Journal:  Curr HIV/AIDS Rep       Date:  2005-11       Impact factor: 5.071

5.  A quarter century of AIDS.

Authors:  Ron Stall; Thomas C Mills
Journal:  Am J Public Health       Date:  2006-05-02       Impact factor: 9.308

6.  Cohort Profile: HAART Observational Medical Evaluation and Research (HOMER) cohort.

Authors:  Sophie Patterson; Angela Cescon; Hasina Samji; Zishan Cui; Benita Yip; Katherine J Lepik; David Moore; Viviane D Lima; Bohdan Nosyk; P Richard Harrigan; Julio S G Montaner; Kate Shannon; Evan Wood; Robert S Hogg
Journal:  Int J Epidemiol       Date:  2014-03-17       Impact factor: 7.196

7.  Engagement in Maximally-Assisted Therapy and Adherence to Antiretroviral Therapy Among a Cohort of Indigenous People Who Use Illicit Drugs.

Authors:  Brittany Barker; Evan Adams; Evan Wood; Thomas Kerr; Kora DeBeck; Huiru Dong; Jean Shoveller; Julio Montaner; M-J Milloy
Journal:  AIDS Behav       Date:  2019-05

8.  Prevalence and Correlates of Reporting Difficulty Taking Antiretroviral Treatment Among HIV-Positive Illicit Drug Users in Vancouver, Canada: A Longitudinal Analysis.

Authors:  Bianca Yeung; N A Mohd Salleh; Eugenia Socías; Huiru Dong; J Shoveller; J S G Montaner; M-J S Milloy
Journal:  AIDS Behav       Date:  2019-05

9.  Physician's manual reporting underestimates mortality: evidence from a population-based HIV/AIDS treatment program.

Authors:  Christopher G Au-Yeung; Aranka Anema; Keith Chan; Benita Yip; Julio S G Montaner; Robert S Hogg
Journal:  BMC Public Health       Date:  2010-10-25       Impact factor: 3.295

10.  Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy.

Authors:  Elena Losina; Bruce R Schackman; Sara N Sadownik; Kelly A Gebo; Rochelle P Walensky; John J Chiosi; Milton C Weinstein; Perrin L Hicks; Wendy H Aaronson; Richard D Moore; A David Paltiel; Kenneth A Freedberg
Journal:  Clin Infect Dis       Date:  2009-11-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.